Anjali Nath

My lab works at the interface of human genetics and drug discovery. We systematically identify connections between genes and the human biology they regulate through the integration of multiomic human datasets. The overarching goals of these analyses are to determine the function of understudied genes and to identify novel druggable targets. We then use the tools of chemical biology in combination with zebrafish genetic models to dissect the molecular mechanisms of these associations and to identify lead compounds. These studies will pave the way for the development of novel small molecules to treat cardiovascular and metabolic diseases.

Companies

• Assistant Professor Harvard Medical School (2020)
• Staff Scientist Beth Israel Deaconess Medical Center (2016)
• Affiliate Member Broad Institute of MIT and Harvard (2012)
• Instructor in Medicine Harvard Medical School (2014 — 2020)
• Postdoctoral Fellow Massachusetts General Hospital (2009 — 2013)
• Postdoctoral Fellow Yale University (2007 — 2008)
• Graduate Student Yale University (2002 — 2007)
• Teaching Fellow II Yale University (2005 — 2006)
• Consultant Cedars-Sinai Medical Center (2002 — 2002)

Education

• Doctor of Philosophy (Ph.D.) Yale University